NMN has Regained its Dietary Supplement Status
NMN (Nicotinamide Mononucleotide) is officially reinstated as a lawful dietary supplement after the FDA’s September 2025 reversal, ending years of regulatory uncertainty. This decision restores access to this key NAD+ precursor and validates its use in custom formulations. The FDA reversed its 2022 action that had classified NMN as a drug candidate. Evidence showed NMN…










